Mireille Kamariza, CEO of OliLux Biosciences — which recently received an investment from Open Philanthropy — is working on a potential breakthrough diagnostic tool to fight tuberculosis.
This federal grant will help support Phase I and II clinical trials over the next 5 years with a goal of providing a new effective once-daily, oral, and...
The development of refrigeration technologies and approaches could have enormous potential, improving the lives of millions of the poorest and most vulnerable people on the planet. Open Philanthropy’s...
